During the past decade, Overland Park Regional Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Overland Park Regional Medical Center" #1 sponsor was "Kansas City Heart Rhythm Research Foundation" with 5 trials, followed by "Harvard Pilgrim Health Care" with 4 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored, "Henry Ford Health System" with 1 trials sponsored and "KC BioMediX, Inc" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Overland Park Regional Medical Center" #1 collaborator was "Rush University" with 5 trials as a collaborator, "University of California, Irvine" with 4 trials as a collaborator, "University of Massachusetts, Amherst" with 4 trials as a collaborator, "Brigham and Women's Hospital" with 3 trials as a collaborator and "Centers for Disease Control and Prevention" with 3 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Overland Park Regional Medical Center" are "Atrial Fibrillation" (3 trials), "Abdominal (ABD) Infection" (1 trials), "Acute Myocardial Infarction" (1 trials), "Atrial Flutter" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Overland Park Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Overland Park Regional Medical Center" are "Other" (6 trials), "Device" (3 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1: Routine Care" (2 trials), "3D electroanatomical mapping alone guided CTI ablation" (1 trials), "AGENT DCB" (1 trials), "Arm 1 (ATP+Shock)" (1 trials) and "Arm 1. Routine Care (Mupirocin/CHG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Overland Park Regional Medical Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Overland Park Regional Medical Center". 5 are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Overland Park Regional Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Overland Park Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".